Lipopolysaccharide binding protein promoter variants influence the risk for Gram-negative bacteremia and mortality after allogeneic hematopoietic cell transplantation.
about
Improving hematopoietic cell transplant outcomes in a new era of genomic researchReduced mortality after allogeneic hematopoietic-cell transplantation.Genetic polymorphisms and posttraumatic complications.Ovocalyxin-36 is a pattern recognition protein in chicken eggshell membranes.NCI, NHLBI first international consensus conference on late effects after pediatric hematopoietic cell transplantation: etiology and pathogenesis of late effects after HCT performed in childhood--methodologic challengesThe contribution of malglycemia to mortality among allogeneic hematopoietic cell transplant recipients.Synergy between acid and endotoxin in an experimental model of aspiration-related lung injury progressionEfficacy of a viral load-based, risk-adapted, preemptive treatment strategy for prevention of cytomegalovirus disease after hematopoietic cell transplantation.Comparison of the effect of recombinant bovine wild and mutant lipopolysaccharide-binding protein in lipopolysaccharide-challenged bovine mammary epithelial cells.Pretransplant neutropenia is associated with poor-risk cytogenetic features and increased infection-related mortality in patients with myelodysplastic syndromesSerum lipopolysaccharide binding protein levels predict severity of lung injury and mortality in patients with severe sepsis.Risk stratification and immunogenetic risk for infections following stem cell transplantationInvolvement of the LPS-LPB-CD14-MD2-TLR4 inflammation pathway in HIV-1/HAART-associated lipodystrophy syndrome (HALS).Identification of single nucleotide polymorphisms in hematopoietic cell transplant patients affecting early recognition of, and response to, endotoxin.Plasma lipopolysaccharide-binding protein and colorectal cancer risk: a nested case-control study in the Multiethnic Cohort.Rethinking Antimicrobial Prophylaxis in the Transplant Patient in the World of Emerging Resistant Organisms-Where Are We Today?Mutations in lipopolysaccharide-binding protein (LBP) gene change the susceptibility to clinical mastitis in Chinese Holstein.
P2860
Q34157754-C2C7EA20-DD11-42CB-BCFB-2DA1FDFEBC71Q34472861-1CD4D59B-B1BE-429D-ACBE-0B9A0CEAA8EAQ34512764-E6D2DD64-0216-4FE3-A324-4E28C5FE780BQ35082830-BF3B010E-E504-4EA1-9FD6-FCCF43F7B23BQ35223947-67B3C2CA-B271-4CC9-BB3A-57E5F534912EQ35235892-F6B0B794-7D09-403A-BBBD-8C9215D2C529Q36297750-5DEFFC45-2396-48DD-823D-59ACB53E7EAEQ36306393-17BC1D02-13C7-4740-8480-0F2EEE98970BQ36814304-C24B9B5C-8D6B-4795-9BB0-DD36D935B9DBQ36984304-F06B8F04-76D4-43AD-A85F-CE6668E3616AQ37313463-B38759FA-9E75-40E2-969F-D0933E0F1DBDQ38950315-4BF01825-A520-405C-AF26-CCCF482D8534Q42236515-3854FE67-F465-4A53-9F2F-4AE5BEDF7370Q42782789-1DBFF957-701C-4568-A142-E4F29D096972Q45946381-66DFA3BD-8D53-483C-B4C1-56550D4675E6Q47709323-6C582986-E28D-4075-A716-ACE791DCFE07Q51558306-F70AA9B9-2E3C-4578-BD9A-AEA2352B4C9B
P2860
Lipopolysaccharide binding protein promoter variants influence the risk for Gram-negative bacteremia and mortality after allogeneic hematopoietic cell transplantation.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Lipopolysaccharide binding pro ...... opoietic cell transplantation.
@ast
Lipopolysaccharide binding pro ...... opoietic cell transplantation.
@en
type
label
Lipopolysaccharide binding pro ...... opoietic cell transplantation.
@ast
Lipopolysaccharide binding pro ...... opoietic cell transplantation.
@en
prefLabel
Lipopolysaccharide binding pro ...... opoietic cell transplantation.
@ast
Lipopolysaccharide binding pro ...... opoietic cell transplantation.
@en
P2093
P2860
P1433
P1476
Lipopolysaccharide binding pro ...... opoietic cell transplantation.
@en
P2093
Jason W Chien
Joan G Clark
John A Hansen
Michael J Boeckh
P2860
P304
P356
10.1182/BLOOD-2007-09-101709
P407
P577
2007-12-03T00:00:00Z